News Article | May 9, 2017
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) today announced that Chairman and CEO Mark T. Bertolini is scheduled to present at the 2017 UBS Global Healthcare Conference in New York City on Monday, May 22, at 10:30 a.m. ET. A live audio webcast will be accessible through the Aetna Investor Relations website at http://www.aetna.com/investor. Interested parties should visit the site prior to the presentation to download and install any necessary audio software. A replay will be available for 14 days. Anyone attending the conference or listening to the meeting is encouraged to read the company’s 2016 Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the first quarter of 2017, including the discussion of risk factors and Aetna's historical results of operations and financial condition contained therein. Those reports are on file with the Securities and Exchange Commission. About Aetna Aetna is one of the nation's leading diversified health care benefits companies, serving an estimated 44.9 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com and learn about how Aetna is helping to build a healthier world. @AetnaNews
News Article | February 15, 2017
FILE - In this Tuesday, Aug. 19, 2014, file photo, a pedestrian walks past a sign for Aetna Inc., at the company headquarters in Hartford, Conn. Aetna and Humana are calling off a $34 billion deal to combine the two major health insurers after a federal judge, citing antitrust concerns, shot down the deal. (AP Photo/Jessica Hill, File) INDIANAPOLIS (AP) -- Major health insurers Aetna and Humana called off their $34 billion combination after a federal judge, citing concerns about prices and benefits, rejected the deal. The announcement Tuesday comes several days after another federal judge shot down a tie-up between two other massive insurers. Blue Cross-Blue Shield carrier Anthem Inc. is attempting to buy Cigna Corp. for $48 billion. Anthem is appealing that decision. Aetna, the nation's third largest insurer, had announced its bid for Humana in 2015. The deal would have given Aetna the opportunity to significantly expand its presence in Medicare Advantage coverage, which involves privately run versions of the federal Medicare program for people who are over 65 or disabled. But Aetna's attempt to gobble up the nation's fifth largest health insurer brought in the Department of Justice, which sued last summer to block that deal and the Anthem-Cigna combination. Regulators worried, in particular, about how the Aetna-Humana deal would affect consumer choices and competition in the fast-growing market for Medicare Advantage plans. U.S. District Judge John Bates wrote in the decision last month that neither new competition nor plans to shed some of the combined company's businesses would be enough to ease antitrust concerns. Federal regulation would likely be "insufficient to prevent the merged firm from raising prices or reducing benefits," Bates ruled. Aetna Chairman and CEO Mark Bertolini said in a company release Tuesday that "the current environment makes it too challenging to continue pursuing the transaction." Humana is entitled to a $1 billion breakup fee, which would amount to about $630 million after taxes. The Louisville, Kentucky, insurer says it will announce its 2017 forecast and provide an update on its strategic plan after markets close Tuesday. The two deals blocked in federal courts would have melded the nation's five largest insurers into three, with UnitedHealth Group Inc. currently the biggest. The insurers have argued that growing through acquisitions would allow them to better negotiate prices with pharmaceutical companies, hospitals and doctor groups that also are merging and growing larger. They also expect to cut expenses and add more customers, which helps them spread out the cost of investing in technology to manage and improve care. Insurers have also said that combining would help them stabilize their business on the Affordable Care Act's public insurance exchanges. But the American Medical Association said last week, after the Anthem-Cigna deal was shot down, that a merger would have created a health care behemoth too large to regulate and with too much control over the lives of consumers. Shares of Hartford, Connecticut-based Aetna Inc. climbed $1.46 to $123.51 late Tuesday morning, while broader indexes slipped. Humana Inc. was down 61 cents to $206.09.
News Article | February 20, 2017
NEW YORK, Feb. 20, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Aetna Inc. ("Aetna" or the "Company") (NYSE:AET) of the March 27, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit...
News Article | February 24, 2017
GRAND RAPIDS, Mich., Feb. 24, 2017 /PRNewswire/ -- NxGen MDx, a Company that provides innovative genetic testing solutions, announced the execution of a new national Agreement with Aetna in a press release issued February 9, 2017 indicating that full-gene sequencing is covered under the...
News Article | February 15, 2017
LONDON, UK / ACCESSWIRE / February 15, 2017 / Active Wall St. blog coverage looks at the headline from Aetna Inc. (NYSE: AET) and Humana Inc. (NYSE: HUM) as both companies announced on February 14, 2017, that they have mutually decided to end their merger agreement announced in July 2015. The decision was taken by both Companies after Judge John D. Bates of the District Court for the District of Columbia blocked the merger in January 2017. Register with us now for your free membership and blog access at: Today, AWS is promoting its blog coverage on AET and HUM. Get all of our free blog coverage and more by clicking on the links below: Commenting on the decision to move away from the merger, Mark T. Bertolini, Chairman and CEO of Aetna said: "We are disappointed to take this course of action after 19 months of planning, but both Companies need to move forward with their respective strategies in order to continue to meet member expectations." Responding on the matter, Bruce D. Broussard, President and CEO of Humana said: "As an independent Company, we will continue to innovate and sharpen our focus on the local healthcare experience of all our members, especially seniors living with chronic conditions." Following the decision to move on, Aetna will pay Humana $1 billion as termination fee. Furthermore, Aetna also announced the cancellation of its agreement with Molina Healthcare, Inc. (NYSE: MOH) to sell some of its Medicare Advantage assets. Aetna has said that it would pay the necessary termination fee to Molina for cancelling the sale agreement. In the same announcement, Aetna announced the complete redemption of its Special Mandatory Redemption Notes (SMRN) for cash on or before March 16, 2017. These $10.2 billion worth of SMRN were issued by Aetna in June 2016 at different interest rates and redemption dates starting from June 2019 – June 2016. These SMRN carry a special mandatory redemption price of 101% of the aggregate principal amount plus any interest accrued and unpaid to, but excluding, the special mandatory redemption date. Going forward, Humana plans to focus and build integrated care for people with chronic conditions – particularly those aging into or already in Medicare Advantage or dual eligible plans. Along with this, the Company plans to focus on the employer group customers by bringing value-added capabilities to this group. Humana will leverage its clinical and operating platforms for enhancing its partnerships with doctors and other healthcare professionals. To achieve the success of this strategic business plan, Humana plans to offer sophisticated population health technology and services, and expanding primary care clinics. Humana plans to expand its clinical capabilities by focusing on the services beyond the conventional doctors' offices and institutions viz., home health services, local pharmacy access and behavioural health. Humana aims to take advantage of analytics and technology to increase transparency and improve interactions between healthcare professionals, Humana's customers and Humana. Humana also plans to discontinue its individual commercial medical coverage from 2018 as it feels that the same is being covered by the on-exchange federal Marketplaces. Humana announced a cash dividend of $0.40 per share to its shareholders, which is payable on April 28, 2017. Humana also plans to increase its shareholders' value by way of share repurchases of over $2 billion in 2017. It plans to complete $1.5 billion accelerated share repurchase program in Q12017 and balance $500 million later on. July 2015 – Two of the largest health insurance Companies in the US - Aetna and Humana announced their decision to merge. Aetna agreed to acquire Humana in a cash plus stock deal of $37 billion. July 2016 – Department of Justice (DOJ) file anti-trust suits in the US District Court which stalled the proposed mergers between Aetna – Humana and another big merger Cigna Corp.- Anthem Inc. All four companies opposed the lawsuit. August 2016 – Aetna reduced its participation in Obamacare. The Company announced to reduce its individual public exchange participation from 778 to 242 counties for 2017. The timing of this move was seen as a pressure tactic to push the government to allow the Aetna – Humana merger. December 2016 – The Antitrust trial against the Aetna-Humana merger brought on by the DOJ started. January 2017 – After a 13-day trial in December 2016, Judge John D. Bates of the District Court for the District of Columbia blocked the Aetna – Humana merger. The Federal Judge ruling stated that the deal violates several federal antitrust laws and would reduce competition in the Medicare Advantage market and in some of the exchanges set up under the Affordable Care Act. At this time, Aetna had considered appealing against the Court's decision but Humana had not made any comments. February 2017 – Aetna and Humana agreed to end merger agreement and move forward. On Tuesday, February 14, 2017, the stock closed the trading session at $125.81, climbing 3.08% from its previous closing price of $122.05. A total volume of 5.14 million shares have exchanged hands, which was higher than the 3-month average volume of 3.07 million shares. Aetna's stock price advanced 5.69% in the last three months, 6.02% in the past six months, and 24.20% in the previous twelve months. Moreover, the stock is trading at a PE ratio of 19.62 and has a dividend yield of 0.79%. Humana's share price finished yesterday's trading session at $205.97, marginally down 0.35%. A total volume of 2.23 million shares exchanged hands, which was higher than the 3 months' average volume of 1.63 million shares. The stock has rallied 15.01% and 24.38% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have gained 1.10%. The stock is trading at a PE ratio of 50.89 and has a dividend yield of 0.56%. Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. AWS has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/. For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
News Article | February 15, 2017
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the mutual termination of its merger agreement with Aetna Inc. (Aetna), following a ruling from the United States District Court for the District of Columbia granting a United States Department of Justice request to enjoin the merger. Under the terms of the merger agreement, Humana is entitled to a breakup fee of $1 billion, or approximately $630 million, net of tax. “The healthcare industry is in a dynamic state, and the public is looking to companies like Humana to improve the cost of care and the consumer experience,” said Bruce D. Broussard, Humana’s President and Chief Executive Officer. “As an independent company, we will continue to innovate and sharpen our focus on the local healthcare experience of all our members, especially seniors living with chronic conditions. Our strategy not only improves the value we bring to members, doctors and other healthcare professionals, but it also helps reduce costs and enhances the growth platform for both our health plans and our Healthcare Services businesses, thus positioning us well for long-term, sustainable growth.” Broussard added, “We are very proud of the tremendous effort and commitment of our associates during this extended period of uncertainty and their continuing focus and dedication to helping our members achieve their best health.” As an independent company, Humana will continue to build upon its integrated care delivery strategy by intensifying its focus on people living with chronic conditions – particularly those aging into or already in Medicare Advantage or dual eligible plans. This population is fast-growing, with greater than 85 percent of seniors having at least one chronic condition and 65 percent having multiple chronic conditions (a). To further advance this strategy, the company will maintain its employer group customer focus, continuing to establish relationships with Medicare age-ins, while leveraging its clinical and operating platforms and furthering partnerships with doctors and other healthcare professionals. This brings value-added capabilities to the company’s employer group customers, particularly small to mid-size employers. As the company’s business model demonstrates, when Humana integrates care with doctors and other healthcare professionals and serves members outside of traditional institutions, its members’ health improves, care is more cost-effective, and consumers are more engaged. These are key drivers to enabling more affordable healthcare for consumers and facilitating higher Star quality ratings, while also improving financial performance. Humana is enhancing its integrated care delivery strategy in several key areas to further enable a rich, locally delivered healthcare experience for members, by doing the following: “By extending and expanding the local capabilities of our Healthcare Services businesses and supporting doctors and other healthcare professionals with innovative and unsurpassed population-health tools, we believe we can remove barriers for our members. This will help them achieve their best health by enabling a more simplified healthcare experience – one that combines the lifestyles of our members and the clinical aspects so critical to improving lifelong health and well-being,” said Broussard. “We believe this will, in turn, continue to drive growth across the enterprise and favorable returns for our stockholders.” The company will continue its practice of evaluating its portfolio of businesses to ensure focus on those lines of business where its integrated care delivery strategy can add value for health plan members, healthcare professionals and its government program and employer group customers. Regarding the company’s individual commercial medical coverage (Individual Commercial), substantially all of which is offered on-exchange through the federal Marketplaces, Humana has worked over the past several years to address market and programmatic challenges in order to keep coverage options available wherever it could offer a viable product. This has included pursuing business changes, such as modifying networks, restructuring product offerings, reducing the company’s geographic footprint and increasing premiums. All of these actions were taken with the expectation that the company’s Individual Commercial business would stabilize to the point where the company could continue to participate in the program. However, based on its initial analysis of data associated with the company’s healthcare exchange membership following the 2017 open enrollment period, Humana is seeing further signs of an unbalanced risk pool. Therefore, the company has decided that it cannot continue to offer this coverage for 2018. Through the remainder of 2017, Humana remains committed to serving its current members across 11 states where it offers Individual Commercial products. And, as it has done in the past, Humana will work closely with its state partners as it navigates this process. The company today also announced strategic changes to its capital deployment plans to increase its return of capital to stockholders and to create capacity for strategic investments. Humana also announced its intention to host an Investor Day in New York, NY on April 25, 2017, where it will provide more detail on the company’s strategic actions and its financial prospects. Specific details for that event will be announced at a later date. Humana provided its Generally Accepted Accounting Principles (GAAP) and Adjusted EPS guidance for FY17 as detailed below. GAAP and Adjusted results for the year ended December 31, 2016 (FY16) are shown below for comparison. Adjusted FY16 results have been recast to exclude the Individual Commercial business given the company’s decision to no longer offer these products beginning in 2018, as discussed above. “Our results for 2016 demonstrated Humana’s ability to maintain operational discipline and advance our strategy during periods of uncertainty and change,” said Brian A. Kane, Senior Vice President and Chief Financial Officer for Humana. “As we head into 2017, this experience increases our confidence that we will continue to drive increased consistency and sustainability of earnings, as well as top and bottom line growth.” Humana will host a conference call and webcast to discuss the announcements in this press release at 4:45 p.m. eastern time today. The webcast may be accessed via Humana’s Investor Relations page at humana.com. The company suggests those listening over the web sign on approximately 15 minutes in advance of the call. The company suggests web participants visit the site well in advance of the call to run a system test and to download any free software needed. For those unable to listen in to the live call, the call replay may be accessed the Historical Webcasts and Presentations section of the Investor Relations page at humana.com, approximately two hours following the live webcast. Telephone replays will be available from 8:15 p.m. eastern time on February 14, 2017 until midnight eastern time on April 14, 2017 and can be accessed by dialing 855-859-2056 and providing the conference ID # 72762971. (c) FY16 Adjusted EPS (Recast) excludes the following: (d) On November 10, 2016, the U.S. Court of Federal Claims ruled in favor of the government in one of a series of cases filed by insurers against the Department of Health and Humana Services (HHS) to collect risk corridor payments, rejecting all of the insurer’s statutory, contract and Constitutional claims for payment. The company had maintained the receivable in previous periods in reliance upon the interpretation previously promulgated by HHS that the risk corridor receivables were obligations of the U.S. government. Given this court decision, however, the company’s conclusion with respect to the ultimate collectability of the receivable has shifted, and accounting rules required that the receivable be written off. Land of Lincoln Mutual Health Insurance Company v. United States; United States Court of Federal Claims No. 16-744C. (e) As noted above, in addition to previously-disclosed adjustments, EPS for FY16 included a strengthening of reserves for the company’s non-strategic closed block of long-term care business. In connection with its acquisition of KMG America in 2007, the company acquired a non-strategic closed block of long-term care insurance policies. These policies were sold between 1995 and 2005, of which approximately 30,800 remained in force as of December 31, 2016. During the fourth quarter of 2016, the company recorded a reserve strengthening for this closed block of policies as it determined the present value of future premiums, together with its existing reserves were not adequate to provide for future policy benefits. This adjustment was primarily driven by emerging experience indicating longer claims duration, a prolonged lower interest rate environment and an increase in policyholder life expectancies. (f) The company’s reserving practice is to consistently recognize the actuarial best estimate of its ultimate benefits expense. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development related to the prior year. In FY16, the company experienced prior period reserve development that exceeded what it would expect in a typical year primarily due to higher than normal claim recoveries. This news release includes forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana’s executive officers, the words or phrases like “expects,” “believes,” “anticipates,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such forward‐looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the “Risk Factors” section of the company’s SEC filings, a summary of which includes but is not limited to the following: In making forward‐looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward‐looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward‐looking statements. Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance: Humana Inc., headquartered in Louisville, Ky., is a leading health and well-being company focused on making it easy for people to achieve their best health with clinical excellence through coordinated care. The company’s strategy integrates care delivery, the member experience, and clinical and consumer insights to encourage engagement, behavior change, proactive clinical outreach and wellness for the millions of people we serve across the country. More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
News Article | February 22, 2017
NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Connecticut on behalf of investors who purchased Aetna Inc. (NYSE:AET) securities between August 15, 2016 through January 20, 2017. Click here to learn about the case: http://www.wongesq.com/pslra/aetna-inc. There is no cost or obligation to you. According to the complaint, throughout the class period Aetna made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/aetna-inc. Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
News Article | February 15, 2017
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the mutual termination of its merger agreement with Aetna Inc. (Aetna), following a ruling from the United States District Court for the District of Columbia granting a United States Department of Justice request to enjoin the merger. Under the terms of the merger agreement, Humana is entitled to a breakup fee of $1 billion, or approximately $630 million, net of tax. As previously disclosed, the company will issue a press release to provide its 2017 financial guidance and provide an update on its strategic plan. To allow for advance notification to investors, Humana has scheduled the issuance of that press release for 4:15 p.m. eastern time today, February 14, 2017, and a call with investors to follow at 4:45 p.m. eastern time. This call will be webcast and may be accessed via Humana’s Investor Relations page at humana.com. The company suggests those listening over the web sign on at least 15 minutes in advance of the call. The company also suggests web participants visit the site well in advance of the call to run a system test and to download any free software needed. For those unable to listen in to the live call, the call replay may be accessed via the Historical Webcasts and Presentations section of the Investor Relations page at humana.com, approximately two hours following the live webcast. Telephone replays will be available from 8:15 p.m. eastern time on February 14, 2017 until midnight eastern time on April 14, 2017 and can be accessed by dialing 855-859-2056 and providing the conference ID # 72762971. Humana Inc., headquartered in Louisville, Ky., is a leading health and well-being company focused on making it easy for people to achieve their best health with clinical excellence through coordinated care. The company’s strategy integrates care delivery, the member experience, and clinical and consumer insights to encourage engagement, behavior change, proactive clinical outreach and wellness for the millions of people we serve across the country. More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
News Article | February 15, 2017
Delta Dental of California and its affiliates today announced the hiring of Dr. Kenneth Yale as senior vice president and chief clinical officer. Dr. Yale brings with him more than 20 years of executive management experience in government, entrepreneurial, startup and large health care companies. Most recently, Dr. Yale served as vice president, medical director and senior counsel at ActiveHealth Management, a subsidiary of Aetna. Prior to that, he led the innovation incubator division of UnitedHealth Community and State and also held positions at Matria Healthcare, CorSolutions, EduNeering, Advanced Health Solutions, Health Solutions Network and Jefferson Group. His government experience includes serving as legislative counsel in the U.S. Senate, executive director of the White House Domestic Policy Council, chief of staff of the White House Office of Science and Technology and commissioned officer in the U.S. Public Health Service. Dr. Yale currently has leadership roles or is actively involved with the American Medical Informatics Association, Bloomberg/BNA Health Insurance Advisory Board, Healthcare Information Management and Systems Society, Society for Participatory Medicine, URAC Industry Accreditation Organization, and on other advisory boards for pharmaceutical, genetics and translational bioinformatics companies and organizations. He holds a dental degree from the University of Maryland School of Dentistry, a law degree from Georgetown University Law Center and a bachelor’s degree in sociology from Creighton University. About Delta Dental of California Delta Dental of California, Delta Dental of New York, Inc., Delta Dental of Pennsylvania and Delta Dental Insurance Company, along with their affiliated companies, together provide dental benefits to 34.5 million people in 15 states plus the District of Columbia and Puerto Rico. All are part of the Delta Dental Plans Association, whose member companies collectively cover more than 73 million people nationwide.
Greg Williams, membre de la direction de la mission des operations et de lexploration humaines de la NASA, interviendra lors de la conference << Capability Counts 2017 >> a Washington, DC, en mai 2017
News Article | February 23, 2017
PITTSBURGH--(BUSINESS WIRE)--Dans une étude récente réalisée par le CMMI Institute, près de 50 % des organisations ont répondu qu’elles n’avaient pas de processus standard en place leur permettant d’adapter rapidement leurs capacités aux opportunités. Pourtant, aujourd’hui plus que jamais, les dirigeants d’entreprise doivent s’assurer que leur organisation satisfait leurs clients au-delà de leurs attentes et innover pour qu’elle se démarque sur le marché. Depuis plus de 25 ans, le CMMI Institute aide des milliers d’organisations – y compris Honeywell, Lockheed Martin, Boeing, Fujitsu, IBM, HP, Microsoft, Oracle, Cisco Systems, et Intel – à évaluer leur capacité organisationnelle et à réaliser de meilleures performances. Profitez de conseils d’expert et des ressources proposées sur l’identification des capacités clés qui définissent votre organisation en participant à la conférence annuelle du CMMI Institute « Capability Counts » qui se tiendra les 16 et 17 mai 2017, à Alexandria, dans l’état de Virginie, en périphérie immédiate de Washington, DC. La conférence présentera comment le CMMI a réussi à proposer à plusieurs reprises des approches exploitables notamment concernant la capacité et la maturité d’une organisation, mais aussi la manière de créer une culture d’amélioration continue. « La capacité constitue la pierre angulaire de toute stratégie, et la stratégie définit la manière dont nous concurrençons avec les autres organisations. La capacité correspond à la capacité d’être concurrentiel », a déclaré M. Kirk Botula, PDG du CMMI Institute. « Le programme de la conférence “Capability Counts 2017” sera axé sur les organisations qui élaborent des stratégies dans le but de générer de la croissance et qui s’appuient sur leurs capacités pour créer une culture d’avantage concurrentiel et d’amélioration constante. » Rejoignez des centaines de professionnels au profil et au parcours variés, venus de divers pays, qui s’intéressent à l’amélioration des capacités et de la performance. Choisissez parmi plus de 80 présentations, des tutoriels pratiques, des panels de discussion interactifs et bien plus encore. Travaillez en face-à-face avec des conseillers et bénéficiez du savoir des experts internationaux du CMMI à l’expertise et au parcours divers. Des experts de Honeywell, Siemens, Garmin, Aetna, la NASA, CAE, MITRE, et Deloitte seront présents et partageront leurs connaissances et leur expérience. Tous les professionnels, quel que soit leur niveau d’expertise, pourront tirer des enseignements de la conférence « Capability Counts 2017 » en matière de meilleures pratiques et de solutions. Créez votre programme personnalisé pour les deux jours de la conférence en sélectionnant les séances auxquelles vous voulez assister selon sept parcours. Rencontrez des experts et découvrez comment leur organisation s’est appuyée sur ses capacités et a dépassé ses concurrents avec des produits et des services qui marchent. Des organisations gouvernementales et du secteur de la santé partageront également leur expérience à travers des témoignages convaincants concernant leur adoption de l’approche du CMMI et l’amélioration de leurs capacités. Ne manquez pas de découvrir comment les organisations qui ont adopté et mis en œuvre l’approche du CMMI en conjonction avec d’autres méthodes comme Agile, SAFe, Kanban et ITIL, ont pu améliorer leur performance. Les participants auront le plaisir d’assister à un grand nombre de présentations passionnantes dont les suivantes : « High Maturity Appraisals - The Top 10 HM Misconceptions », « Harmonizing Agile and CMMI Verification and Validation », « Objective Visionary of CMMI High Maturity Practices with Agile & DevOps Implementation », « CMMI SVC and Consumer Driven Healthcare - Enabling the Future », « Holacracy: Abolish hierarchy while leveraging CMMI to Radically change your organization », et « Scaled Agility in Regulated Environments ». Le CMMI Institute (CMMIInstitute.com) est le leader mondial de la promotion de l’adoption des meilleures pratiques par les personnes, dans les processus et dans les technologies. Le CMMI Institute fournit aux organisations les outils et une assistance leur permettant de mesurer leurs capacités et de développer leur maturité en comparant leurs opérations aux meilleures pratiques et en identifiant les écarts de performance. Depuis plus de 25 ans, des milliers d’organisations hautement performantes, dans divers secteurs, dont ceux de l’industrie aérospatiale, de la finance, des services de santé, des logiciels, de la défense, des transports et des télécommunications, ont bénéficié d’une notation de leur niveau de maturité CMMI et ont démontré qu’elles étaient des partenaires commerciaux et des fournisseurs compétents. Le CMMI Institute fait partie du groupe ISACA, l’association mondiale à but non lucratif qui se consacre à aider les professionnels à réaliser le potentiel positif de la technologie. Pour en savoir plus sur la façon dont le CMMI peut aider votre organisation à améliorer son niveau de performance, consultez le site CMMIinstitute.com.